Table 7.
Benchmarking scheme for selected studies.
| SN | S0 | COVID-19 Symptoms in PD Patients | PD Motor Symptoms | PD Non-Motor Symptoms | Risk Factors | Gold Standard | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1 | S2 | S3 | S4 | S5 | S6 | S7 | S8 | S9 | S10 | S11 | S12 | S13 | S14 | S15 | S16 | ||
| 1 | Antonini et al. [56] (2020) | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | PD + COVID-19 + Pneumonia |
| 2 | Baschi et al. [7] (2020) | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 3 | Brown et al. [163] (2020) | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Pneumonia |
| 4 | Cella et al. [2] (2020) | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 5 | Starmbi et al. [129] (2021) | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 6 | Helmich et al. [6] (2020) | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | PD + COVID-19 + Pneumonia |
| 7 | Khoshnood et al. [5] (2021) | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 8 | Lau et al. [16] (2021) | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ | PD + COVID-19 + Pneumonia |
| 9 | Sulzer et al. [4] (2021) | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 10 | Tsivgoulis et al. [131] (2021) | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ | PD + COVID-19 + Respiratory dysfunctions |
| 11 | Sorbera et al. [130] (2021) | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | PD + COVID-19 + Pneumonia |
S0: Author, S1: Fever, S2: Dry cough, S3: Cough, S4: Shortness of breath, S5: Pneumonia, S6: Delirium, S7: Bradykinesia, S8: Rigidity in throat muscles, S9: Anxiety, S10: Sleep disorder, S11: Hypertension, S12: Fainting, S13: Age, S14: PD duration, S15: PD with COVID-19 and comorbidities, S16: PD with COVID-19 mortality risk factor, ✓: Yes, ✕: No.